Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-01

Clinical Trial Update: Essential Oils for Enhancing QOL in ASD [Phase 2]

View source ↗

Summary

Phase 2 trial investigating essential oils to enhance quality of life in autism spectrum disorder; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Jill Hollway | Conditions: Autism Spectrum Disorder, Quality of Life | Phase 2 | Status: COMPLETED | Results posted: 2021-04-01